Even as Starbucks expands its store network in India, its financials point to pressure on the operating model. Tata Starbucks reported revenue of about Rs 1,277 crore in FY25, up ...

Microsoft tie-up helps Publicis counter the view that tech platforms will sideline agencies, arguing that firms with strong ...

Good afternoon, and welcome to the Netflix Q1 2026 Earnings Interview. I'm Spencer Wang, VP of Finance and Capital Markets. Joining me today are Co-CEOs, Ted Sarandos and Greg Peters; and CFO, Spence ...

Yuri Misnik is the Chief Technology Officer at inDrive, where he leads the company’s global technology strategy. With more than two decades of international experience, Misnik has built and led ...

Hims & Hers (HIMS) stock is down ~40% YTD but remains a "Buy." Learn why compressed valuation and Eucalyptus-led Europe/Japan ...

A combo of the Olympics and the Super Bowl helped NBC rise to the top spot, ending YouTube's 12-month run as the No. 1 media company by viewership Gold-medal-winning U.S. figure skater Alysa Liu and ...

Climate disclosure is moving faster than most companies can operationalize. Driven by regulation, procurement requirements, and investor pressure, the current reporting infrastructure remains costly, ...

Demand for AI freelance skills in 2026 is not growing gradually. It is surging.

Explore the evolving healthcare theme in the Rekha Rakesh Jhunjhunwala portfolio as of March 2026. This deep dive analyzes ...

Detailed price information for Pharmather Hldgs Ltd (PHRM-CN) from The Globe and Mail including charting and trades.

Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and ...

A protein that sits dark and silent in a test tube until it meets its molecular target, then snaps open and glows, sounds ...